The effect of dopamine agonists: The expression of GDNF, NGF, and BDNF in cultured mouse astrocytes

Journal of the Neurological Sciences

Volumn 291, Issue 1-2, 2010, Pages 12-16

  Ohta, Kiyoe ^a   Kuno, Sadako ^b   Inoue, Seiji ^c   Ikeda, Erika ^d   Fujinami, Aya ^d   Ohta, Mitsuhiro ^a,d  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b National Center Hospital of Neurology and Psychiatry   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

BDNF; Dopamine agonist; GDNF; Neurotrophic factor; NGF; Parkinson's disease; Ropinirole

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOMORPHINE; BRAIN DERIVED NEUROTROPHIC FACTOR; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; ROPINIROLE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; MESENCEPHALON; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; APOMORPHINE; ASTROCYTES; BRAIN-DERIVED NEUROTROPHIC FACTOR; BROMOCRIPTINE; CELLS, CULTURED; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; INDOLES; MICE; MICE, INBRED ICR; NERVE GROWTH FACTOR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 77349114649     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.01.013     Document Type: Article

References (28)

1. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1 (2000) 120-129
2. Mufson E.J., Kroin J.S., Sendera T.J., and Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol 57 (1999) 451-484
3. Hoffer B.J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., et al. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 182 (1994) 107-111
4. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., et al. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380 (1996) 252-255
5. Tomac A., Lindqvist E., Lin L.F.H., Ögren S.O., Young D., Hoffer B.J., et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373 (1995) 335-339
6. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290 (2000) 767-773
7. Kearns C.M., and Gash D.M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res 672 (1995) 104-111
8. Ugarte S.D., Lin E., Klann E., Zigmond M.J., and Perez R.G. Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J Neurosci Res 73 (2003) 105-112
9. Kordower J.H., Palfi S., Chen E.Y., Ma S.Y., Sendera T., Cochran E.J., et al. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann Neurol 46 (1999) 419-424
10. Ohta K., Kuno S., Mizuta I., Fujinami A., Matsui H., and Ohta M. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci 73 (2003) 617-626
11. Ohta M., Mizuta I., Ohta K., Nishimura M., Mizuta E., Hayashi K., et al. Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes. Biochem Biophys Res Commun 272 (2000) 18-22
12. Höglinger G.U., Rizk P., Muriel M.P., Duyckaerts C., Oertel W.H., Caille I., et al. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci 7 (2004) 726-735
13. Hofer M., Pagliusi S.R., Hohn A., Leibrock J., and Barde Y.A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 9 (1990) 2459-2464
14. Watabe K., Fukuda T., Tanaka J., Honda H., Toyohara K., and Sakai O. Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities. J Neurosci Res 41 (1995) 279-290
15. Nakajima K., Hida H., Shimano Y., Fujimoto I., Hashitani T., Kumazaki M., et al. GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons. Brain Res 916 (2001) 76-84
16. 2 receptors have to do with it?. Trends Neurosci 29 (2006) 167-174
17. Yan Y., Yamada K., Niwa M., Nagai T., Nitta A., and Nabeshima T. Enduring vulnerability to reinstatement of methamphetamine-seeking behavior in glial cell line-derived neurotrophic factor mutant mice. FASEB J 21 (2007) 1994-2004
18. Camicella S., Kharazia V., Jeanblanc J., Janak P.H., and Ron D. GDNF is a fast-acting potent inhibitor of alcohol consumption and replace. Proc Natl Acad Sci 105 (2008) 8114-8119
19. Green-Sadan T., Kuttner Y., Lublin-Tennenbaum T., Kinor N., Boguslavsky Y., Mangel S., et al. Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats. Exp Neurol 194 (2005) 97-105
20. Kinor N., Geffen R., Golomb E., Zinman T., and Yadid G. Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes. Glia 33 (2001) 143-150
21. Du F., Li R., Huang Y., Li X., and Le W. Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons. Eur J Neurosci 22 (2005) 2422-2430
22. Ling Z.D., Tong C.W., and Carvey P.M. Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures. Brain Res 791 (1998) 137-145
23. 4.4 receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 127 (1999) 1696-1702
24. Miklic S., Juric D.M., and Carman-Krzan M. Differences in the regulation of BDNF and NGF synthesis in cultured neonatal rat astrocytes. Int J Dev Neurosci 22 (2004) 119-130
25. Zafra F., Lindholm D., Castren E., Hartikka J., and Thoenen H. Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J Neurosci 12 (1992) 4793-4799
26. Nagatsu T., Mogi M., Ichinose H., and Togari A. Changes in cytokines and neurotrophines in Parkinson's disease. J Neural Transm 7 (2000) 277-290
27. Nishio T., Furukawa S., Akiguchi I., and Sunohara N. Medial nigral dopamine neurons have rich neurotrophin support in humans. NeuroReport 9 (1999) 2847-2851
28. Parain K., Murer M.G., Yan Q., Faucheux B., Agid Y., Hirsch E., et al. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. NeuroReport 10 (1999) 557-561